Skip to main content

Peer Review reports

From: Drug-related adverse events potentially predict the efficacy of apatinib on advanced hepatocellular carcinoma

Original Submission
16 Dec 2021 Submitted Original manuscript
10 Feb 2022 Reviewed Reviewer Report
31 May 2022 Reviewed Reviewer Report
4 Jul 2022 Author responded Author comments - Xiaoying Gu
Resubmission - Version 2
4 Jul 2022 Submitted Manuscript version 2
19 Jul 2022 Reviewed Reviewer Report
7 Aug 2022 Author responded Author comments - Xiaoying Gu
Resubmission - Version 3
7 Aug 2022 Submitted Manuscript version 3
13 Sep 2022 Author responded Author comments - Xiaoying Gu
Resubmission - Version 4
13 Sep 2022 Submitted Manuscript version 4
Publishing
16 Oct 2022 Editorially accepted
31 Oct 2022 Article published 10.1186/s12876-022-02542-0

You can find further information about peer review here.

Back to article page